PubRank

Christine B Ambrosone

Author PubWeight™ 187.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
2 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
3 The landscape of recombination in African Americans. Nature 2011 3.06
4 IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data. Bioinformatics 2012 2.97
5 Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat 2005 2.75
6 A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010 2.64
7 Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 2009 2.59
8 Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009 2.58
9 A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 2012 2.45
10 Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006 2.42
11 A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008 2.31
12 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
13 Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 2006 2.18
14 Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005 2.03
15 Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet 2011 1.94
16 Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer 2005 1.84
17 A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet 2013 1.82
18 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
19 Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet 2009 1.81
20 Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 2011 1.71
21 The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 2008 1.70
22 The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev 2007 1.69
23 The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J 2012 1.64
24 Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst 2002 1.58
25 Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 2008 1.58
26 Recommendations for collection and handling of specimens from group breast cancer clinical trials. J Clin Oncol 2008 1.50
27 Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet 2011 1.47
28 Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev 2006 1.45
29 Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum Mol Genet 2011 1.45
30 Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat Res 2002 1.44
31 Molecular epidemiology to better predict lung cancer risk. Clin Lung Cancer 2008 1.43
32 Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 2009 1.40
33 Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 2007 1.36
34 Rethinking sources of representative controls for the conduct of case-control studies in minority populations. BMC Med Res Methodol 2013 1.35
35 Breast cancer racial disparities: unanswered questions. Cancer Res 2010 1.35
36 Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst 2010 1.30
37 Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2008 1.30
38 Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005 1.26
39 Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer 2004 1.24
40 Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet 2013 1.24
41 An admixture scan in 1,484 African American women with breast cancer. Cancer Epidemiol Biomarkers Prev 2009 1.22
42 Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res 2012 1.18
43 A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control 2013 1.17
44 Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 2006 1.14
45 Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 2011 1.13
46 Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 2005 1.12
47 Community-based partnership to identify keys to biospecimen research participation. J Cancer Educ 2013 1.12
48 Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007 1.11
49 A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 2012 1.11
50 Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 2004 1.10
51 DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 2008 1.10
52 STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis 2004 1.10
53 Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat 2011 1.10
54 Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2004 1.09
55 Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 2006 1.09
56 Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst 2013 1.09
57 Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol 2011 1.08
58 Pilot intervention outcomes of an educational program for biospecimen research participation. J Cancer Educ 2013 1.08
59 Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer 2003 1.07
60 Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 2011 1.06
61 The role of genetic variability in drug metabolism pathways in breast cancer prognosis. Pharmacogenomics 2006 1.06
62 Intake of cruciferous vegetables modifies bladder cancer survival. Cancer Epidemiol Biomarkers Prev 2010 1.06
63 Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007 1.05
64 Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst 2012 1.04
65 (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers. J Nutr 2007 1.04
66 p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 2006 1.02
67 Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer. J Clin Oncol 2008 1.01
68 Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 2008 1.01
69 Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2007 1.01
70 Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clin Cancer Res 2009 1.01
71 Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 2010 1.01
72 Lifestyle factors and survival in women with breast cancer. J Nutr 2007 1.00
73 Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 2009 0.99
74 Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer 2009 0.99
75 Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat 2012 0.99
76 Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control 2011 0.98
77 Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers. J Nutr 2011 0.98
78 Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin Chim Acta 2007 0.97
79 Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 2011 0.97
80 Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2011 0.97
81 CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2005 0.96
82 Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Res Treat 2006 0.95
83 Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenet Genomics 2005 0.95
84 Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium. Breast Cancer Res Treat 2015 0.95
85 NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer. PLoS One 2012 0.94
86 Body fatness and breast cancer risk in women of African ancestry. BMC Cancer 2013 0.94
87 Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 2006 0.94
88 Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 2006 0.94
89 Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen 2002 0.94
90 Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2011 0.94
91 Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 2006 0.94
92 Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 2005 0.93
93 OSAT: a tool for sample-to-batch allocations in genomics experiments. BMC Genomics 2012 0.93
94 Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry. Int J Cancer 2013 0.93
95 Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis 2007 0.93
96 Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. BMC Cancer 2010 0.93
97 Body size in early life and breast cancer risk in African American and European American women. Cancer Causes Control 2013 0.92
98 A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation. Biol Blood Marrow Transplant 2010 0.92
99 Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2009 0.91
100 Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. J Clin Oncol 2012 0.91
101 SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2004 0.91
102 Exposures associated with serum organochlorine levels among postmenopausal women from western New York State. Am J Ind Med 2002 0.91
103 DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol Biomarkers Prev 2009 0.90
104 PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 2008 0.90
105 Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer. Breast Cancer Res Treat 2010 0.90
106 Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS). PLoS One 2013 0.90
107 Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat 2013 0.90
108 Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study. Gynecol Oncol 2011 0.89
109 Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 2006 0.89
110 Re: "Population- and community-based recruitment of African Americans and Latinos: the San Francisco Bay Area Lung Cancer Study". Am J Epidemiol 2004 0.89
111 Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 2005 0.89
112 Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer. Clin Cancer Res 2010 0.89
113 Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2007 0.88
114 Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res 2014 0.88
115 Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women. Int J Cancer 2013 0.88
116 Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Res Treat 2012 0.87
117 Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival. Breast Cancer Res 2006 0.87
118 Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 2009 0.87
119 Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2011 0.87
120 A genome-wide scan for breast cancer risk haplotypes among African American women. PLoS One 2013 0.87
121 Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial. Am J Epidemiol 2013 0.86
122 MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett 2003 0.86
123 Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women. J Steroid Biochem Mol Biol 2012 0.85
124 Genome-wide association study of age at menarche in African-American women. Hum Mol Genet 2013 0.85
125 MnSOD Val-9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes Control 2005 0.85
126 Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 2010 0.85
127 A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions. Breast 2012 0.85
128 Traumatic stress symptoms and breast cancer: the role of childhood abuse. Child Abuse Negl 2010 0.85
129 Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt) 2015 0.84
130 Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 2009 0.84
131 The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 2002 0.84
132 Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial. Urology 2008 0.83
133 No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005 0.83
134 Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer. Carcinogenesis 2012 0.83
135 Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control 2013 0.83
136 The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data. PLoS Genet 2010 0.83
137 Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer 2014 0.83
138 A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium. Breast Cancer Res 2015 0.82
139 Racial disparities in red meat and poultry intake and breast cancer risk. Cancer Causes Control 2013 0.82
140 Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr 2011 0.82
141 Diet and alcohol consumption in relation to p53 mutations in breast tumors. Carcinogenesis 2004 0.82
142 Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat 2013 0.82
143 Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women. Carcinogenesis 2012 0.81
144 Supplement use during an intergroup clinical trial for breast cancer (S0221). Breast Cancer Res Treat 2013 0.81
145 Modifiable Lifestyle Factors and Breast Cancer Outcomes: Current Controversies and Research Recommendations. Adv Exp Med Biol 2015 0.81
146 Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk. Cancer Causes Control 2012 0.80
147 Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma. Am J Hematol 2014 0.80
148 Gene-nutrient interactions in cancer etiology. Nutr Rev 2004 0.80
149 Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer. Ann Surg Oncol 2014 0.79
150 Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival. Breast Cancer Res Treat 2013 0.79
151 FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors. Int J Cancer 2010 0.79
152 Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila) 2010 0.78
153 Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer. Cancer Causes Control 2013 0.77
154 Comorbidities and Their Management: Potential Impact on Breast Cancer Outcomes. Adv Exp Med Biol 2015 0.77
155 Common genetic variants are associated with accelerated bone mineral density loss after hematopoietic cell transplantation. PLoS One 2011 0.76
156 Length heteroplasmies in human mitochondrial DNA control regions and breast cancer risk. Int J Mol Epidemiol Genet 2010 0.76
157 Genetic variants in the mTOR pathway and breast cancer risk in African American women. Carcinogenesis 2015 0.76
158 Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer 2014 0.75
159 The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective. Int J Mol Epidemiol Genet 2010 0.75
160 Intake of energy-dense foods, fast foods, sugary drinks, and breast cancer risk in African American and European American women. Nutr Cancer 2014 0.75
161 Microsomal epoxide hydrolase variants are not associated with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2002 0.75
162 XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. Int J Mol Epidemiol Genet 2010 0.75
163 Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study. Front Oncol 2013 0.75
164 The launch of international journal of molecular epidemiology and genetics. Int J Mol Epidemiol Genet 2009 0.75
165 Editorial board of international journal of molecular epidemiology and genetics (as of march 31, 2010). Int J Mol Epidemiol Genet 2010 0.75